GridAI Technologies Corp. (GRDX)
NASDAQ: GRDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GRDX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $32.44M
- EPS (TTM)
- -$5.65
- Dividend yield
- None
- 52-week range
- 1.87 – 6.93
- Day range
- 3.12 – 3.56
- Volume / Avg
- 125.15K / 120.78K
- Beta
- —
- Shares outstanding
- 10.27M
52-week range
GRDX stock today
GridAI Technologies (GRDX) closed at $3.16 on Nov 20, down 8.41% (-$0.29), versus the S&P 500's 3.70% decline. Shares are 54.4% below their 52-week high of $6.93, set on Jun 1, 2026 and 69.0% above the 52-week low of $1.87, in the middle of the past year's range. GRDX is down 32.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 20.6%.
GridAI Technologies has posted a net loss over the last twelve months (EPS of -$5.65), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About GridAI Technologies
Company profileGridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Jason David Sawyer
- Headquarters
- Edinburgh, FL
- IPO year
- 2016
- Website
- grid-ai.com
Financial highlights
Full financialsIn fiscal 2025, GridAI Technologies generated $36,251 in revenue. GridAI Technologies reported a net loss of $6.4 million, compared with a loss of $18.1 million a year earlier. Gross margin was -1813.6% and operating margin -19540.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $36.25K | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-6.39M | $-18.06M | $-15.79M | $-14.63M | $-58.54M |
| EPS (diluted) | $-4.16 | $-15.99 | $-47.88 | $-416.94 | $-1,988.53 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 18, 2026
- EPS actual vs est.
- $-0.27 vs —
GRDX news
All GRDX newsGridAI Technologies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HYFTMindWalk Holdings Corp. | 0.6844 | -14.27% | $32.56M | vs GRDX |
| FLNAFilana Therapeutics Inc. | 0.6413 | +14.52% | $32.26M | vs GRDX |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.05 | -1.87% | $33.01M | vs GRDX |
| VERUVeru Inc. | 1.94 | -8.06% | $33.08M | vs GRDX |
| CUECue Biopharma Inc. | 4.15 | -7.78% | $34.69M | vs GRDX |
| SERSerina Therapeutics Inc. | 1.12 | -6.67% | $29.76M | vs GRDX |
| NXTCNextCure Inc. | 6.45 | -4.87% | $29.53M | vs GRDX |
| NNVCNanoViricides Inc. | 1.14 | -2.56% | $29.13M | vs GRDX |
Indexes, lists and sector
GridAI Technologies stock FAQ
What is GridAI Technologies's stock price today?
GRDX last traded at $3.16 as of Nov 20, 4:00 PM EST, down 8.41% on the day. Prices are delayed at least 15 minutes.
Does GridAI Technologies pay a dividend?
No. GridAI Technologies does not currently pay a regular cash dividend.
Who is GridAI Technologies's CEO?
Mr. Jason David Sawyer is the chief executive officer of GridAI Technologies Corp..
Has GRDX ever split its stock?
Yes. The most recent GRDX stock split was a 1-for-3 split on Aug 18, 2025, one of 5 splits on record.
What is the GRDX 52-week high?
The 52-week high for GRDX is $6.93 and the 52-week low is $1.87. The stock is currently 54.4% below its high.